Hopen Life Science Ventures
12
20M
10
2
0.17
2
- Stages of investment
- Areas of investment
Summary
The main office of represented VC is situated in the Grand Rapids. The fund was located in North America if to be more exact in United States.
The high activity for fund was in 2014. The fund is generally included in less than 2 deals every year. Speaking about the real fund results, this VC is 11 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this Hopen Life Science Ventures performs on 20 percentage points less the average number of lead investments. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2015.
The typical case for the fund is to invest in rounds with 4 participants. Despite the Hopen Life Science Ventures, startups are often financed by Triathlon Medical Venture Partners, North Coast Technology Investors, JumpStart Inc.. The meaningful sponsors for the fund in investment in the same round are Venture Investors, Frazier Healthcare Partners, Beringea. In the next rounds fund is usually obtained by Rev1 Ventures, Ohio TechAngels Fund, Chrysalis Ventures.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Cirius Therapeutics, Metabolic Solutions Development, Delphinus Medical Technologies We can highlight the next thriving fund investment areas, such as Pharmaceutical, Therapeutics.
The overall number of key employees were 2.
Investments analytics
Analytics
- Total investments
- 12
- Lead investments
- 2
- Exits
- 2
- Follow on index
- 0.17
- Investments by industry
- Biotechnology (10)
- Medical (5)
- Medical Device (5)
- Health Care (5)
- Therapeutics (4) Show 8 more
- Investments by region
-
- United States (11)
- Canada (1)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Avg. valuation at time of investment
- 6M
- Group Appearance index
- 0.83
- Avg. company exit year
- 12
- Avg. multiplicator
- 3.11
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Delphinus Medical Technologies | 10 Sep 2015 | Biotechnology, Health Care, Medical Device, Medical | Late Stage Venture | 39M | United States, Michigan |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.